These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34136717)

  • 1. Old drugs for a new indication: a review of chloroquine and analogue in COVID-19 treatment.
    Ehianeta TS; Akinyeye RO; Orege JI; Ejeromedoghene O; Adebule AP; Okonkwo BO
    Porto Biomed J; 2021; 6(3):e132. PubMed ID: 34136717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.
    Verbaanderd C; Maes H; Schaaf MB; Sukhatme VP; Pantziarka P; Sukhatme V; Agostinis P; Bouche G
    Ecancermedicalscience; 2017; 11():781. PubMed ID: 29225688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
    Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19.
    Adeel AA
    Sudan J Paediatr; 2020; 20(1):4-9. PubMed ID: 32528194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
    Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
    Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
    Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
    Chen Y; Shen T; Zhong L; Liu Z; Dong X; Huang T; Wang Q; Xiao H
    Front Pharmacol; 2020; 11():1167. PubMed ID: 32848774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19.
    Peng H; Chen Z; Wang Y; Ren S; Xu T; Lai X; Wen J; Zhao M; Zeng C; Du L; Zhang Y; Cao L; Hu J; Wei X; Hong T
    Front Pharmacol; 2020; 11():554172. PubMed ID: 33192503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
    Acharya Y; Sayed A
    Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
    Martinez GP; Zabaleta ME; Di Giulio C; Charris JE; Mijares MR
    Curr Pharm Des; 2020; 26(35):4467-4485. PubMed ID: 32634079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
    Giri A; Das A; Sarkar AK; Giri AK
    Genes Environ; 2020; 42():25. PubMed ID: 32884603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing New Use for Old Drug Chloroquine against Metabolic Syndrome: A Review on Animal and Human Evidence.
    Wong SK
    Int J Med Sci; 2021; 18(12):2673-2688. PubMed ID: 34104100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine in COVID-19 Patients: Pros and Cons.
    Younis NK; Zareef RO; Al Hassan SN; Bitar F; Eid AH; Arabi M
    Front Pharmacol; 2020; 11():597985. PubMed ID: 33364965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools.
    Hathout RM; Abdelhamid SG; Metwally AA
    Inform Med Unlocked; 2020; 21():100446. PubMed ID: 33052313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
    Richard SA; Kampo S; Hechavarria ME; Sackey M; Buunaaim ADB; Kuugbee ED; Anabah TW
    J Immunol Res; 2020; 2020():4582612. PubMed ID: 33062720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.
    Warhurst DC; Steele JC; Adagu IS; Craig JC; Cullander C
    J Antimicrob Chemother; 2003 Aug; 52(2):188-93. PubMed ID: 12837731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.